Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells.

G G Burrows1, Y K Chou, C Wang

  • 1Department of Neurology, Oregon Health and Science University, Portland, OR 97201, USA. ggb@ohsu.edu

Journal of Immunology (Baltimore, Md. : 1950)
|October 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.

Mucosal immunology·2010
Same author

Toxic effects of non-steroidal anti-inflammatory drugs in a human intestinal epithelial cell line (HCT-8), as assessed by the MTT and neutral red assays.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Comparison of LDH, (51)Cr, and BCECF efflux as indices of non-steroidal anti-inflammatory drug-induced toxicity in human gastro-intestinal (HGT-1, HCT-8 and T84) cell lines: BCECF efflux is not an index of plasma membrane integrity.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis.

Journal of neuroimmunology·2010
Same author

Peptide therapy for anti-CD4 autoimmunity in HIV-1 infection: toward the development of an autoimmune animal model.

Vaccine·2009
Same author

Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression.

Neuroscience·2008

Recombinant T cell receptor (TCR) ligands provide minimal activation signals, revealing rudimentary TCR engagement patterns. This approach offers a novel strategy for generating bystander suppression to treat autoimmune diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Autoimmune Diseases

Background:

  • T cell activation involves complex interactions between antigen-presenting cells (APCs) and T helper 1 (Th1) cells.
  • Dissecting T cell receptor (TCR) signaling from costimulatory signals is crucial for understanding T cell activation.

Purpose of the Study:

  • To develop a minimal ligand for peptide-specific TCRs to dissociate Ag-specific signaling from costimulatory signaling.
  • To investigate the rudimentary signaling patterns induced by initial TCR engagement.

Main Methods:

  • Construction of recombinant TCR ligands (RTLs) by covalently linking HLA-DR2b domains with specific peptides.
  • Incubation of peptide-specific Th1 cell clones with RTLs in the absence of APCs or costimulatory molecules.
  • Analysis of TCR signaling events, cytokine production, and cell proliferation upon RTL stimulation and subsequent restimulation with APCs/peptide.

Related Experiment Videos

Main Results:

  • Cognate RTLs induced partial TCR activation, including TCR zeta-chain phosphorylation, calcium mobilization, and IL-10 production, without proliferation.
  • RTL-pretreated Th1 clones exhibited reduced proliferation and IFN-gamma secretion upon restimulation.
  • IL-10 production persisted after restimulation, suggesting sustained regulatory effects.

Conclusions:

  • Initial engagement of the external TCR interface delivers a rudimentary signaling pattern, which is augmented by co-stimulatory molecules.
  • RTL-mediated activation offers a novel strategy for inducing autoantigen-specific bystander suppression.
  • This approach holds potential for treating complex autoimmune diseases.